Summary of Deadly? COVID 19 Pneumonia and ARDS

00:00:00 - 00:05:00

The video discusses the effects of COVID19 pneumonia on the body, and how the pneumonia may lead to ARDS. ARDS is a serious condition, and approximately 25-40% of those who develop it do not survive. Treatment options for ARDS patients are improving, but many patients do not recover fully. The video discusses the effects of Covid19 pneumonia on the lungs, and how treatment typically involves outpatient care. The patient's FEV1 (air flow from the lungs in one second) decreased after treatment, but has since rebounded. Pulmonary function testing and chest imaging were also performed at various points during treatment and showed improvement. Patients are encouraged to seek out lung specialists if they are concerned about their lung health.

• 00:00:00 This video discusses the effects of COVID19 pneumonia on the body, and how the pneumonia may lead to ARDS. ARDS is a serious condition, and approximately 25-40% of those who develop it do not survive. Treatment options for ARDS patients are improving, but many patients do not recover fully.
• 00:05:00 The video discusses the effects of Covid19 pneumonia on the lungs, and how treatment typically involves outpatient care. The patient's FEV1 (air flow from the lungs in one second) decreased after treatment, but has since rebounded. Pulmonary function testing and chest imaging were also performed at various points during treatment and showed improvement. Patients are encouraged to seek out lung specialists if they are concerned about their lung health.